Table 2 Summary of Predictors of mortality in HIV-associated TB patients in Serowe/Palapye district Botswana 2013

 < 35

1

–

–

–

 35–59

0.89 (0.46–1.7)

0.722

1.5 (0.75–3)

0.245

 ≥ 60

3.15 (1.28–7.73)

0.012

4.8 (1.8–13)

0.002

 Male sex

1.22 (0.67–2.23)

0.513

–

–

 Unemployed

1.2 (0.59–2.42)

0.627

–

–

Smoker

2.53 (0.76–8.42)

0.130

0.66 (0.13–3.4)

0.619

 Body weight < 50 kg

2.1 (0.94–4.71)

0.072

1.8 (0.7–4.5)

0.205

 Smear positive PTB

0.5 (0.27–0.93)

0.028

–

–

 Extrapulmonary

1.12 (0.59–2.13)

0.739

–

–

 Previous TB

0.74 (0.27–2.01)

0.571

–

–

 Fever

1.58 (0.85–2.94)

0.153

–

–

 Productive cough

0.94 (0.46–1.92)

0.870

–

–

 Night sweats

0.55 (0.26–1.16)

0.116

–

–

 Loss of weight

2.33 (1.07–5.04)

0.032

–

–

 Duration of symptoms > 3 months

3.85 (0.47–31)

0.207

–

–

 No ART use during TB treatment

2.49 (1.31–4.73)

0.005

5.6 (2.9–11)

< 0.001

 ART naïve

1.2 (0.66–2.2)

0.569

–

–

 OI other than TB

7.76 (3.96–15.25)

< 0.001

8.5 (4–18.4)

< 0.001

 CD4 counts cells/μl at TB < 200

2.02 (1.01–4.04)

0.046

–

–

 Hemoglobin < 10 g/dl

2.4 (1.3–4.5)

0.007

2.44 (1.3–4.6)

0.029

 Major Side effect

4.84 (2–12.3)

0.001

5 (1.6–17)

0.007

 IRIS

1.1 (0.53–2.27)

0.808

–

–

 Diabetes mellitus

0.049 (0–2559)

0.586

–

–